-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Estrella Immunopharma, Inc. quarterly Liabilities and Equity history and growth rate from Q3 2021 to Q2 2024.
- Estrella Immunopharma, Inc. Liabilities and Equity for the quarter ending June 30, 2024 was $4.45M, a 47.1% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)